NEW ZEALAND GAZETTE, No. 49 — 8 MAY 2015

provisions:
(a) the following *warning statement is required: ‘Suitable only for pre-term infants under specialist medical
supervision’; and
(b) the name of food must include the words ‘pre-term’.

Note The labelling provisions are set out in Standard 1.2.1.

2.9.1—14 Products for metabolic, immunological, renal, hepatic and malabsorptive conditions

(1) A compositional requirement of this Standard does not apply to the extent that it would prevent the sale of an
infant formula product that is specifically formulated to satisfy particular metabolic, immunological, renal, hepatic
or malabsorptive conditions.

(2) If:
(a) an infant formula product would not comply with this Standard apart from this section; and
(b) the label contains a statement that the infant formula product is suitable for infants with metabolic,
immunological, renal, hepatic or malabsorptive conditions;

then for the labelling provisions, a statement indicating the following is required:
(c) that the product is not suitable for general use and should be used under medical supervision; and
(d) the condition, disease or disorder for which the product has been specially formulated; and
(e) the nutritional modifications, if any, which have been made to the product.

Note The labelling provisions are set out in Standard 1.2.1.

Special requirements for food represented as lactose free and low lactose formulas

(3) A compositional or labelling requirement of this Standard, other than a requirement that relates to lactose
content, applies to an infant formula product that is represented as lactose free formula or low lactose formula.

(4) If the formula is represented as lactose free, it must contain no detectable lactose.

(5) If the formula is represented as low lactose, it must contain no more than 0.3 g lactose/100 mL of infant
formula product.

(6) For the labelling provisions, if a label contains a claim that the infant formula product is lactose free, low
lactose or words of similar import:
(a) the name of food must include the following:
(i) for a formula represented as lactose free—the words ‘lactose free’; and
(ii) for a formula represented as low lactose—the words ‘low lactose’; and
(b) the following statements are required:
(i) the amount of lactose expressed in g/100 mL; and
(ii) the amount of galactose expressed in g/100 mL.

Note The labelling provisions are set out in Standard 1.2.1.

2.9.1—15 Products for specific dietary use based on a protein substitute

(1) The protein content of an infant formula product based on a *protein substitute may be in the form of a protein
substitute.

(2) Such infant formula product must:
(a) have an energy content of:
(i) for an infant formula—no less than 2 500 kJ/L and no more than 3 150 kJ/L; and
(ii) for a follow-on formula—no less than 2 500 kJ/L and no more than 3 550 kJ/L; and
(b) have a potential renal solute load of no more than 8 mOsm/100 kJ; and
(c) have a protein content of no less than 0.45 g/100 kJ and no more than 1.4 g/100 kJ; and
(d) have a fat content of no less than 0.93 g/100 kJ and no more than 1.5 g/100 kJ; and
(e) contain:
(i) chromium in an amount of no less than 0.35 μg/100 kJ and no more than 2.0 μg/100 kJ; and
(ii) molybdenum in an amount of no less than 0.36 μg/100 kJ and no more than 3.0 μg/100 kJ.

(3) Section 2.9.1—10 applies to such infant formula product as if it were infant formula.

(4) Such infant formula product may contain added medium chain triglycerides.

119